GTC Biotherapeutics (fka GTCB)

[biopearl]

Dew, Have of course made the transition from Yahoo to ihub to keep track of your message board, worth the trip. Have been in this stock probably as long as you and plan to stay for the duration. I am curious and your memory will probably serve to answer this question. Back in the days of creation, there was morning there was night, there was Genzyme, Genzyme Tissue Repair, Genzyme Oncology, doing vaccine work and there was Genzyme trangenics now GTC-B (the later not structured as a tracking company of Genzyme.) We know the fate of the so called tracking companies and the preservation of the independent stature of GTCB (the survivor of sorts). There was something called an investors protection plan that was voted on to protect guys like me who lost not only their shirts but major portions of their wardrobes in the tracking company debacle. So to the question. What stops the acquisition of GTCB at these low prices? Are we "protected" in some way? And was this the reference to the 19.9% regarding recent structure of deal with LFB? Thanks, bp